Back

Efficacy and safety of drug-coated balloon angioplasty in patients with acute coronary syndromes: insights from the REC-CAGEFREE I trial

29 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Novel aspects of the revascularisation of patients with chronic and acute coronary syndromes Revascularisation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Chao Gao

First Affiliated Hospital of University of Science and Technology of China, Hefei (China)

5 More presentations in this session

Presentation thumbnail
Plaque inflammation and noncalcified burden predict adverse events after percutaneous coronary intervention
Doctor Z. Lu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Left anterior descending artery lesions retain excess risk despite coronary angiography derived-fractional flow reserve concordant revascularisation
Miss H. Sze (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Effects of colchicine on platelet reactivity among stable post-myocardial infarction patients: a double-blind randomized controlled trial.
Doctor M. Andrade (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Comparing the impact of intravascular imaging, fractional flow reserve, and angiographic guidance on one-year outcomes of PCI in patients with chronic coronary syndromes: an emulated trial
Mr B. Ratanasumawong (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Can lipoprotein(a) predict the need for coronary artery revascularization in a chronic setting?
Doctor D. Besic (Zagreb, HR)
Abstract Slides Video

Access the full session

Session thumbnail
Novel aspects of the revascularisation of patients with chronic and acute coronary syndromes

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Drug-coated balloon versus drug-eluting stent following orbital atherectomy for calcified coronary artery: one-year outcomes of a retrospective cohort study
27 August 2021
thumbnail
Congress Presentation
Clinical presentation, management, and in-hospital outcomes of acute coronary syndrome in active cancer patients vs. survivors
21 June 2025
thumbnail
Congress Presentation
Discussant review - REC-CAGEFREE I
2 September 2024
thumbnail
Congress Presentation
Deescalating measures for chronic coronary syndrome: as stable as an atherosclerotic plaque can be.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources